Lin M, Yin Y, Zhao X, Wang C, Zhu X, Zhan L
Nat Commun. 2025; 16(1):1386.
PMID: 39910047
PMC: 11799228.
DOI: 10.1038/s41467-025-56302-1.
Yamaue R, Torikai M, Terashima M, Mori H
Vaccines (Basel). 2024; 12(7).
PMID: 39066391
PMC: 11281633.
DOI: 10.3390/vaccines12070753.
Honemann M, Maier M, Frille A, Thiem S, Bergs S, Williams T
Viruses. 2024; 16(6).
PMID: 38932235
PMC: 11209376.
DOI: 10.3390/v16060943.
Miller R, Mousa J
Curr Opin Virol. 2023; 61:101337.
PMID: 37544710
PMC: 10421620.
DOI: 10.1016/j.coviro.2023.101337.
Powell T, Jacobs A, Tang J, Cardenas E, Palath N, Daniels J
Vaccines (Basel). 2022; 10(12).
PMID: 36560488
PMC: 9785538.
DOI: 10.3390/vaccines10122078.
Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein.
Harshbarger W, Abeyrathne P, Tian S, Huang Y, Chandramouli S, Bottomley M
MAbs. 2021; 13(1):1955812.
PMID: 34420474
PMC: 8386734.
DOI: 10.1080/19420862.2021.1955812.
Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.
Jo W, Schadenhofer A, Habierski A, Kaiser F, Saletti G, Ganzenmueller T
Proc Natl Acad Sci U S A. 2021; 118(14).
PMID: 33811145
PMC: 8040649.
DOI: 10.1073/pnas.2026558118.
Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Broadbent L, Guo Parke H, Ferguson L, Millar A, Shields M, Detalle L
Antimicrob Agents Chemother. 2019; 64(2).
PMID: 31767728
PMC: 6985719.
DOI: 10.1128/AAC.02034-19.
RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.
Wilmschen S, Schneider S, Peters F, Bayer L, Issmail L, Banki Z
Vaccines (Basel). 2019; 7(3).
PMID: 31277325
PMC: 6790003.
DOI: 10.3390/vaccines7030059.
The role of the light chain in the structure and binding activity of two cattle antibodies that neutralize bovine respiratory syncytial virus.
Ren J, Nettleship J, Harris G, Mwangi W, Rhaman N, Grant C
Mol Immunol. 2019; 112:123-130.
PMID: 31100550
PMC: 6677920.
DOI: 10.1016/j.molimm.2019.04.026.
Transient opening of trimeric prefusion RSV F proteins.
Gilman M, Furmanova-Hollenstein P, Pascual G, van t Wout A, Langedijk J, McLellan J
Nat Commun. 2019; 10(1):2105.
PMID: 31068578
PMC: 6506550.
DOI: 10.1038/s41467-019-09807-5.
Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.
Xie Q, Wang Z, Ni F, Chen X, Ma J, Patel N
PLoS One. 2019; 14(2):e0210749.
PMID: 30730999
PMC: 6366758.
DOI: 10.1371/journal.pone.0210749.
Sequence Analysis of the Fusion Protein Gene of Human Respiratory Syncytial Virus Circulating in China from 2003 to 2014.
Song J, Wang H, Ng T, Cui A, Zhu S, Huang Y
Sci Rep. 2018; 8(1):17618.
PMID: 30514963
PMC: 6279739.
DOI: 10.1038/s41598-018-35894-3.
Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset.
Mas V, Nair H, Campbell H, Melero J, Williams T
Vaccine. 2018; 36(45):6660-6673.
PMID: 30292456
PMC: 6203811.
DOI: 10.1016/j.vaccine.2018.09.056.
Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.
Clark C, Guerrero-Plata A
Curr Clin Microbiol Rep. 2018; 4:202-207.
PMID: 30009126
PMC: 6040676.
DOI: 10.1007/s40588-017-0074-6.
Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein.
Jaberolansar N, Chappell K, Watterson D, Bermingham I, Toth I, Young P
Sci Rep. 2017; 7(1):11130.
PMID: 28894111
PMC: 5593926.
DOI: 10.1038/s41598-017-10415-w.
Neutralizing epitopes of RSV and palivizumab resistance in Japan.
Hashimoto K, Hosoya M
Fukushima J Med Sci. 2017; 63(3):127-134.
PMID: 28867684
PMC: 5792496.
DOI: 10.5387/fms.2017-09.
Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.
Vandini S, Biagi C, Lanari M
Int J Mol Sci. 2017; 18(8).
PMID: 28783078
PMC: 5578107.
DOI: 10.3390/ijms18081717.
Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.
Lau J, Kim Y, Murphy R, Newman R, Yang X, Zody M
Virology. 2017; 510:289-296.
PMID: 28779686
PMC: 5580249.
DOI: 10.1016/j.virol.2017.07.017.
Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
Hause A, Henke D, Avadhanula V, Shaw C, Tapia L, Piedra P
PLoS One. 2017; 12(4):e0175792.
PMID: 28414749
PMC: 5393888.
DOI: 10.1371/journal.pone.0175792.